Wendell David Associates Inc Bristol Myers Squibb CO Transaction History

Wendell David Associates Inc

  • $1.01 Billion
  • Q4 2024

A detailed history of Wendell David Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wendell David Associates Inc holds 20,201 shares of BMY stock, worth $1.19 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
20,201
Previous 19,209 5.16%
Holding current value
$1.19 Million
Previous $994,000 14.99%
% of portfolio
0.11%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$51.92 - $59.94 $51,504 - $59,460
992 Added 5.16%
20,201 $1.14 Million
Q3 2024

Oct 21, 2024
SELL
$39.66 - $51.75 $20,424 - $26,651
-515 Reduced 2.61%
19,209 $994,000
Q1 2024

Apr 22, 2024
SELL
$47.98 - $54.4 $10,939 - $12,403
-228 Reduced 1.14%
19,724 $1.07 Million
Q4 2023

Jan 22, 2024
BUY
$48.48 - $57.85 $41,353 - $49,346
853 Added 4.47%
19,952 $1.02 Million
Q3 2023

Oct 20, 2023
BUY
$57.89 - $64.73 $46,312 - $51,784
800 Added 4.37%
19,099 $1.11 Million
Q2 2021

Jul 19, 2021
SELL
$61.91 - $67.42 $49,218 - $53,598
-795 Reduced 4.16%
18,299 $1.22 Million
Q1 2021

Apr 20, 2021
SELL
$59.34 - $66.74 $20,116 - $22,624
-339 Reduced 1.74%
19,094 $1.21 Million
Q4 2020

Jan 22, 2021
BUY
$57.74 - $65.43 $9,931 - $11,253
172 Added 0.89%
19,433 $1.21 Million
Q3 2020

Oct 20, 2020
SELL
$57.43 - $63.64 $2,871 - $3,182
-50 Reduced 0.26%
19,261 $1.16 Million
Q2 2020

Jul 17, 2020
SELL
$54.82 - $64.09 $8,223 - $9,613
-150 Reduced 0.77%
19,311 $1.14 Million
Q1 2020

Apr 16, 2020
SELL
$46.4 - $67.43 $34,800 - $50,572
-750 Reduced 3.71%
19,461 $1.09 Million
Q4 2019

Jan 17, 2020
BUY
$49.21 - $64.19 $284,187 - $370,697
5,775 Added 40.0%
20,211 $1.3 Million
Q3 2019

Oct 22, 2019
SELL
$42.77 - $50.71 $4,277 - $5,071
-100 Reduced 0.69%
14,436 $732,000
Q2 2019

Jul 16, 2019
SELL
$44.62 - $49.34 $22,310 - $24,670
-500 Reduced 3.33%
14,536 $659,000
Q1 2019

Apr 11, 2019
SELL
$45.12 - $53.8 $9,024 - $10,760
-200 Reduced 1.31%
15,036 $717,000
Q4 2018

Jan 17, 2019
SELL
$48.76 - $63.23 $85,281 - $110,589
-1,749 Reduced 10.3%
15,236 $792,000
Q2 2018

Jul 16, 2018
SELL
$50.53 - $62.98 $32,895 - $40,999
-651 Reduced 3.69%
16,985 $940,000
Q1 2018

Apr 11, 2018
SELL
$59.92 - $68.98 $5,992 - $6,898
-100 Reduced 0.56%
17,636 $1.12 Million
Q4 2017

Jan 16, 2018
BUY
$59.94 - $65.35 $92,907 - $101,292
1,550 Added 9.58%
17,736 $1.09 Million
Q3 2017

Oct 17, 2017
BUY
$55.23 - $63.74 $893,952 - $1.03 Million
16,186
16,186 $1.03 Million

Others Institutions Holding BMY

# of Institutions
2,596
Shares Held
1.46B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wendell David Associates Inc Portfolio

Follow Wendell David Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email